| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.24B | +5.2% |
| Cost of Revenue | $4.07B | +1.8% |
| Gross Profit | $3.17B | +10.0% |
| R&D Expense | $116.6M | +8.0% |
| SG&A Expense | $1.34B | +5.6% |
| Operating Income | $1.30B | +11.7% |
| Pre-tax Income | $1.13B | +9.9% |
| Income Tax | $262.5M | +9.4% |
| Net Income | $838.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.54B | -3.4% |
| Accounts Receivable | $1.34B | +8.2% |
| Inventory | $1.05B | +5.4% |
| Current Assets | $4.16B | +2.8% |
| Total Assets | $18.01B | +15.7% |
| Current Liabilities | $1.82B | -0.5% |
| Long-term Debt | $4.75B | +76.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Financing Cash Flow | $1.71B | +605.9% |
| +7.7% |
| EPS (Basic) | $2.08 | +8.3% |
| EPS (Diluted) | $2.06 | +8.4% |
| Total Liabilities |
| $7.76B |
| +35.8% |
| Stockholders' Equity | $10.18B | +4.0% |